GlaxoSmithKline (GSK) Reports Q1 EPS of GBP0.19; Lowers FY14 EPS Growth Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
InterMune (ITMN) Higher on Takeover Chatter
July 21, 2014 10:37 AM EDTInterMune (NASDAQ: ITMN) is solidly higher today (+3.9%) following reports from Betaville over the weekend that GlaxoSmithKline plc (NYSE: GSK) is exploring a takeover of the company.
"Good sources tell me the FTSE 100 giant has... More
